Europe — EMA
Olanzapina Bluepharma (Olanzapine)
Olanzapine, the active ingredient in Olanzapina Bluepharma, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapina Bluepharma, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapina Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapina Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olanzapine used for?
Olanzapine is an atypical antipsychotic that modulates dopamine and serotonin pathways in several psychiatric conditions.
- Schizophrenia: helps reduce positive and negative symptoms and lowers risk of relapse. - Bipolar I disorder: assists to stabilise mood during manic or mixed episodes. - Psychotic depression: augments antidepressant therapy to improve depressive and psychotic symptoms. - Schizoaffective disorder : provides a combined control of psychotic and mood features. - Tou Tou
